July 7, 2016 Test aids prostate cancer treatment Genomic Health Inc. has struck a deal to commercialize a new blood test that can help advanced prostate cancer patients decide whether to try costly new-generation drugs or rely on much cheaper traditional chemotherapy to improve their chances for survival.
July 5, 2016 Testosterone gel boosts sexual desire and activity in older men Older men with low testosterone levels and scant desire for sex report more interest and more sexual activity after testosterone therapy, according to a new study.
June 30, 2016 Following prevention guidelines linked to lowered risk for cancer Keeping active and eating healthy really does seem to reduce the odds of getting certain cancers and dying from them, according to a new review of past research.
June 30, 2016 More physical activity linked to less risk for cancer Higher levels of leisure-time activity may boost protection against a wide range of cancers, according to a new analysis of research from the U.S. and Europe.
June 30, 2016 Avoid biopsies with more accurate prostate cancer screening Although prostate cancer is the second most common cancer among American men, treatment has resulted in a 99 percent average five-year survival rate for diagnosed individuals, according to the Centers for Disease Control and Prevention.
June 27, 2016 Racially biased cancer doctors spend less time with black patients Racial bias on the part of a doctor can lead to poor communication and medical treatment for black cancer patients, a U.S. study suggests.
June 19, 2016 Ken Griffey Sr., Jr., take a crack at prostate cancer MLB’s famous father-son duo Ken Griffey Sr. and Jr. have long-been household names due to their remarkable careers on the baseball field.
May 24, 2016 What is HIFU treatment for prostate cancer? In October 2015, the U.S. Food and Drug Administration (FDA) approved the first ultrasound system for the ablation of prostate tissue in the United States.
May 17, 2016 HIV-infected patients less likely to get cancer treatment HIV-infected cancer patients are much less likely to receive treatment for tumors than people who don't have the virus, a large U.S. study suggests.